Justin Gainor

37PUBLICATIONS
353CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Tumour immunologyInnate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (37)

|May 13, 2026
Recalibrating Dual Checkpoint Blockade? Lessons from Volrustomig.

|Mar 26, 2026
Final Efficacy and Safety Data From the Phase I/II ARROW Study of Pralsetinib in Patients With Advanced <i>RET</i> Fusion-Positive Non-Small Cell Lung Cancer.

Benjamin Besse, Vivek Subbiah, Giuseppe Curigliano

|Jan 15, 2026
Landscape of Genomic Mechanisms of Resistance to Selective RET Inhibitors in RET-Altered Solid Tumors: Analysis of the RETgistry Global Consortium.

Sarah Waliany, Alissa J Cooper, Stephen V Liu

|Jan 14, 2026
Circulating Tumor Cells Predict Response to the DLL3-Targeting Bispecific Antibody Tarlatamab.

Avanish Mishra, Catherine B Meador, Kruthika Kikkeri

|Jul 24, 2025
Machine-learning driven strategies for adapting immunotherapy in metastatic NSCLC.

Maliazurina B Saad, Qasem Al-Tashi, Lingzhi Hong

|Mar 27, 2025
Oxidation of retromer complex controls mitochondrial translation.

Junbing Zhang, Md Yousuf Ali, Harrison Byron Chong

Pageof 7

Frequent Collaborators

6 joint publications

Jessica J Lin

6 joint publications

Mari Mino-Kenudson

5 joint publications

John V Heymach

4 joint publications

Yasir Y Elamin